Roosevelt Institute | Cornell University

Biosimilars: The Future for the United States Pharmaceutical Industry

By Holly Grace Published October 27, 2016

Biosimilars are biologic medicines that are produced in living cells through multi-step processes. Unlike generic drugs, which are made through chemical synthesis, the environment biosimilars are created in impacts them. With numerous leading prescription drugs losing their patents in the next few years, pharmaceutical companies are eagerly seeking ways to provide new products that are difficult to replicate and biosimilars seem to be the solution.

Reaching Out to Teens to Help Stop Hunger

By Holly Grace Published September 29, 2016

No Kid Hungry, the BackPack Program, and Feed the Children are just a few of the numerous programs that have been created in recent years to end child hunger. With 1 in 6 children in the United States facing hunger, it is nationally recognized that children from impoverished families should be given nutritious food to help with their growth and development.

Do-It-Yourself Healthcare Improves Cost-Effectiveness in the United States

By Holly Grace Published March 23, 2016

In a country that spends a large portion of its GDP on healthcare, the cost-effectiveness of this care is extremely lacking, causing people to turn to Do-It-Yourself products to diagnose their illnesses. Startup companies are embracing this opening in the market by developing new apps and other forms of technology for consumers to use.